Hideki Goto
Sapporo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 95 publications
Comparative outcomes of lisocabtagene maraleucel versus an external control arm in third-line or later relapsed or refractory follicular lymphoma.
Journal: Leukemia & lymphoma
Published: April 29, 2026
Body Mass Index and Outcomes after CD19 Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory B-Cell Lymphoma: A Nationwide Registry Study.
Journal: Transplantation and cellular therapy
Published: April 27, 2026
Immunocomplex capture fluorescence analysis for donor selection in HLA-haploidentical peripheral blood stem cell transplantation.
Journal: Transplant immunology
Published: April 02, 2026
Characteristics of progressive multifocal leukoencephalopathy in hematological malignancies, With reference to HIV-infected patients.
Journal: International journal of hematology
Published: April 01, 2026
Philadelphia chromosome-negative but BCR::ABL1-positive acute lymphoblastic leukemia: a real-world multicenter cohort study.
Journal: International journal of hematology
Published: February 24, 2026
Decreased renal function predicts severe cytokine release syndrome after CAR-T-cell therapy for large B-cell lymphoma.
Journal: British journal of haematology
Published: February 03, 2026
Efficacy and safety of subcutaneous mosunetuzumab plus polatuzumab vedotin in patients with relapsed/refractory large B-cell lymphoma: Japan subgroup analysis of the phase III SUNMO trial.
Journal: International journal of clinical oncology
Published: January 06, 2026
PLK1 inhibition enhances Brentuximab vedotin efficacy in CD30-positive T-cell lymphoma via spindle assembly checkpoint activation.
Journal: Leukemia
Published: December 28, 2025
CRS and ICANS in CAR T-cell therapy for large B-cell lymphoma.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: December 24, 2025
Last Updated: 09/26/2026